Coronavirus 

Further reading: ESG didn’t immunise stocks against the crash

Further reading: ESG didn’t immunise stocks against the crash

The asset management industry is often hasty to boast about how superior environmental, social and governance (ESG) standards boost investment performance, and the crisis this year has been no exception. Data provider Morningstar went so far as to refer to ESG as an “equity vaccine” against the pandemic-induced market sell-off in February and March, reporting that 24 of 26 ESG-tilted index funds outperformed their closest conventional counterparts over the sell-off.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now